Othera Pharmaceuticals, Inc.
|Othera Pharmaceuticals, Inc. Patent applications|
|Patent application number||Title||Published|
|20080312283||Use of Hydroxylamine Derivates for Inhibiting Vitrectomy-Induced Cataracts - Methods to prevent, inhibit, or slow the development of vitrectomy-induced cataracts are disclosed. The methods comprise administering to the eye of a subject a composition comprising an opthalmologically acceptable carrier or diluent and at least one hydroxylamine compound in a therapeutically sufficient amount to prevent, inhibit, or slow the development of a vitrectomy-induced cataract in the subject to which the composition is administered.||12-18-2008|
Patent applications by Othera Pharmaceuticals, Inc.